Exacerbation of COVID 19 in Hypertensive Patients ( A review)

Since its discovery in December 2019, corona virus was outbreak worldwide with very rapid rate, so it described by WHO as pandemic. It associated with severe acute respiratory distress syndrome, and can enter to cells through Angiotensin Converting Enzyme 2 (ACE 2) receptor which play an important r...

Full description

Bibliographic Details
Main Authors: Noor Hatef Naser, Ammar Abdul Aziz Alibeg
Format: Article
Language:English
Published: College of Pharmacy University of Baghdad 2021-12-01
Series:Iraqi Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1286
_version_ 1819095985180114944
author Noor Hatef Naser
Ammar Abdul Aziz Alibeg
author_facet Noor Hatef Naser
Ammar Abdul Aziz Alibeg
author_sort Noor Hatef Naser
collection DOAJ
description Since its discovery in December 2019, corona virus was outbreak worldwide with very rapid rate, so it described by WHO as pandemic. It associated with severe acute respiratory distress syndrome, and can enter to cells through Angiotensin Converting Enzyme 2 (ACE 2) receptor which play an important role as regulator for blood pressure. Hypertension is a potential risk factor for sever acute respiratory syndrome COVID-19, and associated with high mortality rate as shown in many epidemiological studies. Moreover, specific antihypertensive medications that infected patients were receiving are not known; only data about renin-angiotensin-aldosterone system (RAAS) are available.
first_indexed 2024-12-21T23:52:00Z
format Article
id doaj.art-20766f054d784f48a1adbeddf76a44df
institution Directory Open Access Journal
issn 2521-3512
1683-3597
language English
last_indexed 2024-12-21T23:52:00Z
publishDate 2021-12-01
publisher College of Pharmacy University of Baghdad
record_format Article
series Iraqi Journal of Pharmaceutical Sciences
spelling doaj.art-20766f054d784f48a1adbeddf76a44df2022-12-21T18:45:54ZengCollege of Pharmacy University of BaghdadIraqi Journal of Pharmaceutical Sciences2521-35121683-35972021-12-01302233010.31351/vol30iss2pp23-30872Exacerbation of COVID 19 in Hypertensive Patients ( A review)Noor Hatef Naser0Ammar Abdul Aziz AlibegFaculty of pharmacy/ Kufa universitySince its discovery in December 2019, corona virus was outbreak worldwide with very rapid rate, so it described by WHO as pandemic. It associated with severe acute respiratory distress syndrome, and can enter to cells through Angiotensin Converting Enzyme 2 (ACE 2) receptor which play an important role as regulator for blood pressure. Hypertension is a potential risk factor for sever acute respiratory syndrome COVID-19, and associated with high mortality rate as shown in many epidemiological studies. Moreover, specific antihypertensive medications that infected patients were receiving are not known; only data about renin-angiotensin-aldosterone system (RAAS) are available.https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1286covid-19, hypertension, angiotensin converting enzyme 2 (ace2)
spellingShingle Noor Hatef Naser
Ammar Abdul Aziz Alibeg
Exacerbation of COVID 19 in Hypertensive Patients ( A review)
Iraqi Journal of Pharmaceutical Sciences
covid-19, hypertension, angiotensin converting enzyme 2 (ace2)
title Exacerbation of COVID 19 in Hypertensive Patients ( A review)
title_full Exacerbation of COVID 19 in Hypertensive Patients ( A review)
title_fullStr Exacerbation of COVID 19 in Hypertensive Patients ( A review)
title_full_unstemmed Exacerbation of COVID 19 in Hypertensive Patients ( A review)
title_short Exacerbation of COVID 19 in Hypertensive Patients ( A review)
title_sort exacerbation of covid 19 in hypertensive patients a review
topic covid-19, hypertension, angiotensin converting enzyme 2 (ace2)
url https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1286
work_keys_str_mv AT noorhatefnaser exacerbationofcovid19inhypertensivepatientsareview
AT ammarabdulazizalibeg exacerbationofcovid19inhypertensivepatientsareview